A carregar...
Safety and Efficacy of Fingolimod in Treatment-Naïve Multiple Sclerosis Patients
Fingolimod was recently approved for use in the United States after two phase III trials confirmed its effectiveness in reducing disease activity in relapsing-remitting multiple sclerosis. These positive results, coupled with the important fact that this is the first oral disease-modifying therapy,...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Libertas Academica
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3663606/ https://ncbi.nlm.nih.gov/pubmed/23861637 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/JCNSD.S5120 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|